| Literature DB >> 2937372 |
H Hurvitz, E Kerem, E Gross-Kieselstein, A Brand, D Branski.
Abstract
Pancytopenia after intramuscular iron-dextran treatment occurred in an infant with Down's syndrome. Haematological abnormalities recurred on subsequent challenge. Positive migration inhibiting factor and mast cell degranulation tests support an allergic pathogenesis for the pancytopenia. These side effects have not been reported previously.Entities:
Mesh：
Substances：
Year: 1986 PMID： 2937372 PMCID： PMC1777573 DOI： 10.1136/adc.61.2.194
Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791